The global atherosclerosis drugs market is expected to grow from USD 45.55 billion in 2022 to USD 55.19 billion by 2030, at a CAGR of 2.43% during the forecast period 2022-2030. The North American region is expected to d...
The global anti-inflammatory drugs market is expected to grow from USD 95.23 billion in 2022 to USD 164.97 billion by 2030, at a CAGR of 7.11% during the forecast period 2022-2030. The North American region anti-inflamma...
The global pruritus therapeutics market is expected to grow from USD 9.64 billion in 2022 to USD 12.43 billion by 2030, at a CAGR of 3.23% during the forecast period 2022-2030. The Asia Pacific is expected to grow the fa...
The global genome editing market was valued at USD 5.89 billion in 2022, increasing at a CAGR of 16.85% from 2022 to 2030 and anticipated to reach USD 20.47 billion by 2030. The global genome editing market was val...
The global cell therapy market is expected to grow from USD 22.43 billion in 2022 to USD 127.90 billion by 2030, at a CAGR of 24.31% during the forecast period 2022-2030. The North American region cell therapy market sha...
The global endoscopy devices market was valued at USD 38.21 billion in 2022, increasing at a CAGR of 7.60% from 2022 to 2030 and anticipated to reach USD 68.65 billion by 2030. North America is expected to grow the faste...
The global nerve repair and regeneration market are expected to grow from USD 7.54 billion in 2022 to USD 20.20 billion by 2030, at a CAGR of 13.11% during the forecast period 2022-2030. The Asia Pacific is expected to g...
The global minimal residual disease market was valued at USD 1259.20 million in 2022, increasing at a CAGR of 15.28% from 2022 to 2030 and anticipated to reach USD 3927.60 million by 2030. The Asia Pacific is expected to...
The global weight loss and weight management market is expected to reach USD 405.37 billion by 2030, at a CAGR of 6.8% from 2022 to 2030. Weight loss and weight management market growth would be driven by increasing bari...
The global platelet-rich plasma market is expected to reach USD 2006.26 million by 2030, at a CAGR of 13.44% from 2022 to 2030. Platelet-rich plasma is used in many research studies to develop new drugs. The increasing u...
Page 26 of 38